William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
BioMedNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation in William Blair Biotech Focus Conference
-
Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021
-
Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021
-
VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021
-
VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021
-
F-star Therapeutics to Present at Upcoming Investor Conferences
-
Tempest to Participate in William Blair 2021 Biotech Focus Conference
-
Tempest to Participate in William Blair 2021 Biotech Focus Conference
-
F-star Therapeutics to Present at Upcoming Investor Conferences
-
UPDATE: William Blair Starts Latch, Inc. (LTCH) at Outperform
-
Ramaco Resources, Inc. Announces Upsizing and Pricing of Senior Unsecured Notes Offering
-
Apexigen to Participate in Upcoming Investor Conferences
-
Atlanticus Holdings Corporation Announces Closing of Over-Allotment Option in Connection with Offering of Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Holdings Corporation Announces Closing of Over-Allotment Option in Connection with Offering of Series B Cumulative Perpetual Preferred Stock
-
Celcuity to Participate in the William Blair Biotech Focus Conference
-
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021
-
Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021
-
Adamas to Present at Upcoming William Blair Biotech Focus Conference
-
Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021
-
Neurocrine Biosciences to Participate at the William Blair Biotech Focus Conference
-
iTeos Therapeutics to Present at William Blair Biotech Focus Conference 2021
-
iTeos Therapeutics to Present at William Blair Biotech Focus Conference 2021
-
Pluralsight Completes Acquisition of A Cloud Guru to Accelerate its Push to Solve the Growing Cloud Skills Gap
-
Albireo to Present at the William Blair Biotech Focus Conference 2021
-
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
-
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
-
Vaccitech to Present at the William Blair Biotech Focus Conference 2021
-
ReCode Therapeutics to Present at William Blair Biotech Focus Conference 2021
-
BeyondSpring to Participate in the William Blair Biotech Focus Conference
-
Selecta Biosciences to Participate at the William Blair Biotech Focus Conference 2021
-
Generation Bio to Present at William Blair Biotech Focus Conference
-
Generation Bio to Present at William Blair Biotech Focus Conference
-
9 Meters Biopharma, Inc. To Present at the William Blair Biotech Focus Conference
-
Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021
-
Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021
-
Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021
-
Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021
-
Taysha Gene Therapies to Participate in Upcoming July Investor Healthcare Conference
-
Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021
-
Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021
-
LogicBio Therapeutics to Participate in William Blair Biotech Focus Conference 2021
-
Post-Fed taper tantrum? Not this time, market strategists say
-
Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference
-
Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference
-
Sera Prognostics (SERA) Announces 4.7M Share IPO at $15-$17/sh
-
Form D/A William Blair Macro Allo
-
Form D/A William Blair Internatio
-
Merus to Participate in William Blair's Biotech Focus Conference 2021
-
Merus to Participate in William Blair's Biotech Focus Conference 2021
-
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021

